Australia markets close in 2 hours 38 minutes

Cryo-Cell International, Inc. (CCEL)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
8.29-0.02 (-0.24%)
At close: 03:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 67.35M
Enterprise value 77.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.19
Price/book (mrq)N/A
Enterprise value/revenue 2.48
Enterprise value/EBITDA -6.87

Trading information

Stock price history

Beta (5Y monthly) 0.55
52-week change 365.80%
S&P500 52-week change 323.57%
52-week high 38.67
52-week low 33.67
50-day moving average 36.65
200-day moving average 35.74

Share statistics

Avg vol (3-month) 311.31k
Avg vol (10-day) 310.98k
Shares outstanding 58.1M
Implied shares outstanding 68.1M
Float 83.87M
% held by insiders 147.22%
% held by institutions 110.81%
Shares short (15 Apr 2024) 416.87k
Short ratio (15 Apr 2024) 41.18
Short % of float (15 Apr 2024) 40.31%
Short % of shares outstanding (15 Apr 2024) 40.21%
Shares short (prior month 15 Mar 2024) 426.54k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 309 Sept 2022
Ex-dividend date 401 Sept 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin -31.02%
Operating margin (ttm)10.39%

Management effectiveness

Return on assets (ttm)-0.93%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)31.37M
Revenue per share (ttm)3.78
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)N/A
EBITDA 166.4k
Net income avi to common (ttm)-9.73M
Diluted EPS (ttm)-1.16
Quarterly earnings growth (yoy)-27.50%

Balance sheet

Total cash (mrq)1.06M
Total cash per share (mrq)0.13
Total debt (mrq)11.56M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.49
Book value per share (mrq)-1.25

Cash flow statement

Operating cash flow (ttm)6.92M
Levered free cash flow (ttm)-6.34M